The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 21, 2010
Filed:
Feb. 25, 2005
Michitaka Sato, Kawasaki, JP;
Teruaki Matsui, Kawasaki, JP;
Akira Asagarasu, Machida, JP;
Hiroyuki Hayashi, Kawasaki, JP;
Sei-ichi Araki, Kawasaki, JP;
Satoru Tamaoki, Kamakura, JP;
Nobuyuki Takahashi, Handa, JP;
Yukinao Yamauchi, Kawasaki, JP;
Yoshiko Yamamoto, Kawasaki, JP;
Norio Yamamoto, Kawasaki, JP;
Chisato Ogawa, Kawasaki, JP;
Michitaka Sato, Kawasaki, JP;
Teruaki Matsui, Kawasaki, JP;
Akira Asagarasu, Machida, JP;
Hiroyuki Hayashi, Kawasaki, JP;
Sei-ichi Araki, Kawasaki, JP;
Satoru Tamaoki, Kamakura, JP;
Nobuyuki Takahashi, Handa, JP;
Yukinao Yamauchi, Kawasaki, JP;
Yoshiko Yamamoto, Kawasaki, JP;
Norio Yamamoto, Kawasaki, JP;
Chisato Ogawa, Kawasaki, JP;
ASKA Pharmaceutical Co., Ltd., Tokyo, JP;
Abstract
This invention provides pyrimidine derivatives represented by a formula, or a salt thereof, which concurrently exhibit 5-HTagonistic activity and 5-HTantagonistic activity and are useful for therapy and treatments of diseases such as IBS. The invention furthermore provides a therapeutic method of IBS, characterized by having 5-HTagonistic activity and 5-HTantagonistic activity work simultaneously and cooperatively in vivo, which comprises either administering 5-HTantagonistic agent which concurrently exhibits 5-HTagonistic activity, or administering 5-HTagonistic agent and 5-HTantagonistic agent simultaneously, in sequence or at an interval.